Early capsule structure changes associated with Cryptococcus neoformans crossing of the blood brain barrier;Cryptococcus neoformans change de capsule après la traversée de la barrière hémato-encéphalique

Medecine/Sciences

Volumn 21, Issue 8-9, 2005, Pages 685-687

  Charlier, Caroline ^a   Chrétien, Fabrice ^b   Lortholary, Olivier ^a,c   Dromer, Françoise ^a  

^a INSTITUT PASTEUR   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BRAIN BARRIER; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; NONHUMAN; NOTE; PATHOPHYSIOLOGY;

FILOBASIDIELLA NEOFORMANS;

EID: 30344467870     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2005218-9685     Document Type: Note

References (7)

1. rd Interscience Conference on Antimicrobial Agents and Chemotherapy, september 2003: M-1752.
2. French N, Gray K, Watera C, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 2002; 16: 1031-8.
3. Garcia-Hermoso D, Dromer F, Mathoulin-Pelissier S, Janbon G. Are two Cryptococcus neoformans strains epidemiologically linked? J Clin Microbiol 2001; 39: 1402-6.
4. Lortholary O, Improvisi L, Nicolas M, et al. Fungemia during murine cryptococcosis sheds some light on pathophysiology. Med Mycol 1999; 37: 169-74.
5. Lortholary O, Improvisi L, Rayhane N, et al. Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection. Infect Immun 1999; 67: 6314-20.
6. Chrétien F, Lortholary O, Kansau I, et al. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis 2002; 186: 522-30.
7. Charlier C, Chrétien F, Baudrimont M, et al. Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol 2005; 166: 421-32.